Skip to content

Impact of Automatic Polyp Detection System on Adenoma Detection Rate

Impact of Automatic Polyp Detection System on Adenoma Detection Rate-a Multicenter,Prospective, Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03967756
Enrollment
1118
Registered
2019-05-30
Start date
2019-06-01
Completion date
2021-10-01
Last updated
2021-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Polyps, Colorectal Adenomas

Brief summary

In recent years, with the continuous development of artificial intelligence, automatic polyp detection systems have shown its potential in increasing the colorectal lesions. Yet, whether this system can increase polyp and adenoma detection rates in the real clinical setting is still need to be proved. The primary objective of this study is to examine whether a combination of colonoscopy and a deep learning-based automatic polyp detection system is a feasible way to increase adenoma detection rate compared to standard colonoscopy.

Interventions

DEVICEAutomatic polyp detection system

When colonoscopists withdraw the colonoscopies and inspect the colons, the video streaming of colonoscopies was real-time switched to the automatic polyp detection system, which made it feasible to detect lesions in real time. When any potential polyp is detected by the system, there will be a tracing box on an adjacent monitor to locate the lesion with a simultaneous sound alarm.

Sponsors

The First Affiliated Hospital of Dalian Medical University
CollaboratorOTHER
Wenzhou Central Hospital
CollaboratorOTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
CollaboratorOTHER
Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged between 40-85 years old who have indications for screening, surveillance and diagnostic. * Patients who have signed inform consent form.

Exclusion criteria

* Patients who have undergone colonic resection * Patients with intracranial and/or central nervous system disease, including cerebral infarction and cerebral hemorrhage. * Patients with severe chronic cardiopulmonary and renal disease. * Patients who are unwilling or unable to consent. * Patients who are not suitable for colonoscopy * Patients who received urgent or therapeutic colonoscopy * Patients with pregnancy, inflammatory bowel disease, polyposis of colon, colorectal cancer, or intestinal obstruction * Patients who are taking aspirin, clopidogrel or other anticoagulants * Patients with withdrawal time \< 6 min

Design outcomes

Primary

MeasureTime frameDescription
adenoma detection rate(ADR)30 minutesthe number of patients with at least one adenoma divided by the total number of patients.

Secondary

MeasureTime frameDescription
polyp detection rate(PDR)30 minutesthe number of patients with at least one polyp divided by the total number of patients.
adenoma per colonoscopy30 minutesthe number of adenomas detected during colonoscopy withdraw divided by the number of colonoscopies.
polyp per colonoscopy30 minutesthe number of polyps detected during colonoscopy withdraw divided by the number of colonoscopies.

Countries

China

Contacts

Primary ContactZhaoshen Li, M.D
li.zhaoshen@hotmail.com86-21-31161365
Backup ContactYu Bai, M.D
baiyu1998@hotmail.com86-21-31161335

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026